Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates

Kundel F, Tosatto L, Whiten DR, Wirthensohn DC, Horrocks MH, Klenerman D.

FEBS J. 2018 Oct;285(19):3604-3630. doi: 10.1111/febs.14409. Epub 2018 Mar 4.

Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives

Baker DJ, Petersen RC.

J Clin Invest. 2018 Apr 2;128(4):1208-1216. doi: 10.1172/JCI95145. Epub 2018 Feb 19.

Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

Tonda-Turo C, Origlia N, Mattu C, Accorroni A, Chiono V.

Curr Med Chem. 2018;25(41):5755-5771. doi: 10.2174/0929867325666180221125759.

Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease

Weinshenker D.

Trends Neurosci. 2018 Apr;41(4):211-223. doi: 10.1016/j.tins.2018.01.010. Epub 2018 Feb 20.

Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases

Kreutzer AG, Nowick JS.

Acc Chem Res. 2018 Mar 20;51(3):706-718. doi: 10.1021/acs.accounts.7b00554. Epub 2018 Mar 6.

Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases

Mohammadi A, Amooeian VG, Rashidi E.

Curr Gene Ther. 2018;18(1):45-63. doi: 10.2174/1566523218666180302163029.

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease

Chan PC, Wei CY, Hung GU, Chiu PY.

Brain Behav. 2018 Feb 5;8(3):e00916. doi: 10.1002/brb3.916. eCollection 2018 Mar.

Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer's disease patients

Peraza LR, Cromarty R, Kobeleva X, Firbank MJ, Killen A, Graziadio S, Thomas AJ, O'Brien JT, Taylor JP.

Sci Rep. 2018 Mar 15;8(1):4637. doi: 10.1038/s41598-018-22984-5.

(123)I-ioflupane SPET and (123)I-MIBG in the diagnosis of Parkinson's disease and parkinsonian disorders and in the differential diagnosis between Alzheimer's and Lewy's bodies dementias

Nuvoli S, Palumbo B, Malaspina S, Madeddu G, Spanu A.

Hell J Nucl Med. 2018 Jan-Apr;21(1):60-68. doi: 10.1967/s002449910707. Epub 2018 Mar 20.

Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration

Cortés N, Andrade V, Guzmán-Martínez L, Estrella M, Maccioni RB.

Int J Mol Sci. 2018 Mar 23;19(4):956. doi: 10.3390/ijms19040956.

REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?

Galbiati A, Carli G, Hensley M, Ferini-Strambi L.

J Alzheimers Dis. 2018;63(1):1-11. doi: 10.3233/JAD-171164.

Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data

Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, Aziz N, Shabbir A, Ali M, Sun T.

Molecules. 2018 Apr 2;23(4):814. doi: 10.3390/molecules23040814.

Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease

Roalf DR, Rupert P, Mechanic-Hamilton D, Brennan L, Duda JE, Weintraub D, Trojanowski JQ, Wolk D, Moberg PJ.

J Neurol. 2018 Jun;265(6):1365-1375. doi: 10.1007/s00415-018-8841-8. Epub 2018 Apr 4.

Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease)

Foguem C, Manckoundia P.

Curr Neurol Neurosci Rep. 2018 Apr 8;18(5):24. doi: 10.1007/s11910-018-0835-5.

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan Y, Nicolazzo JA.

Adv Drug Deliv Rev. 2018 Oct;135:62-74. doi: 10.1016/j.addr.2018.04.009. Epub 2018 Apr 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias